Y. Ikeda et al., THERAPEUTIC EFFECTS OF LOCAL-DELIVERY OF DEXAMETHASONE ON EXPERIMENTAL BRAIN-TUMORS AND PERITUMORAL BRAIN EDEMA, Journal of neurosurgery, 79(5), 1993, pp. 716-721
To determine if dexamethasone administered by osmotic pump directly to
brain tumors would control peritumoral edema and at the same time sup
press tumor growth and prolong survival, the authors studied experimen
tal brain tumors produced in 102 rabbits by implanting VX2 carcinoma c
ells. Of these, 58 animals were separated into three treatment groups:
Group 1 included 15 untreated rabbits; Group 2 included 18 rabbits tr
eated with systemic dexamethasone (4 mg/kg/day); and Group 3 included
25 rabbits treated with local dexamethasone (0.24 mg/day) delivered by
osmotic pump. Systemic or local dexamethasone was administered from D
ay 3 or Day 7 after tumor implantation, and animals were sacrificed on
Day 13. A survival study was performed with 44 rabbits separated into
the same treatment groups, beginning drug delivery on Day 7. Brain wa
ter content in the white matter of sacrificed animals was measured by
the specific gravity method. The length and width of the brain tumors
in all animals were measured and the tumor volume estimated. Findings
showed that systemic and local dexamethasone administered from Day 3 o
r Day 7 was associated with a significant (5% level) inhibition of tum
or volume as well as a mean reduction of brain edema in most tested si
tes. Systemic and local dexamethasone therapy also resulted in a signi
ficant (5% level) increase in survival time relative to the untreated
group. These short-term results suggest that locally delivered dexamet
hasone may constitute a clinically important therapeutic modality.